PureTech to Present at 38th Annual J.P. Morgan Healthcare Conference and Other Conferences
PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that members of its management team will present at the 38th Annual J.P. Morgan Healthcare Conference and other upcoming virtual conferences.
- PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that members of its management team will present at the 38th Annual J.P. Morgan Healthcare Conference and other upcoming virtual conferences.
- Webcasts of the presentations will be available at https://investors.puretechhealth.com .
- View the full release here: https://www.businesswire.com/news/home/20201221005161/en/
PureTechs founder and chief executive officer, Daphne Zohar, president and chief of business and strategy, Bharatt Chowrira, J.D., Ph.D., and chief innovation officer, Eric Elenko, Ph.D., will present at three upcoming conferences. - These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future.